Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic)

被引：0

作者：

Mohamed Hamidou

Antoine Néel

Joel Poupon

Zahir Amoura

Mikael Ebbo

Jean Sibilia

Jean-Francois Viallard

Benjamin Gaborit

Christelle Volteau

Jean Benoit Hardouin

Eric Hachulla

François Rieger

机构：

[1] Department of Internal Medicine,Department of Biological Toxicology

[2] CHU Nantes,Department of Internal Medicine 2, Centre National de Référence pour le Lupus, Institut E3M

[3] Nantes Université,Service de Médecine Interne

[4] AP-HP,Department of Rheumatology

[5] Lariboisière Hospital,Department of Internal Medicine

[6] University Paris VII,Plateforme de Méthodologie et Biostatistiques, CHU Nantes

[7] Hôpital Pitié-Salpétrière,Department of Internal Medicine, Centre de Référence des Maladies Autoimmunes Systémiques Rares du Nord et Nord

[8] Aix Marseille Univ,Ouest de France (CeRAINO)

[9] APHM,undefined

[10] CNRS,undefined

[11] INSERM,undefined

[12] CIML,undefined

[13] Hôpital de la Timone,undefined

[14] University of Strasbourg,undefined

[15] Haut-Lévêque University Hospital,undefined

[16] Université de Nantes,undefined

[17] INSERM UMR 1246-SPHERE,undefined

[18] Université de Nantes,undefined

[19] University of Lille,undefined

[20] MEDSENIC,undefined

[21] SAS,undefined

[22] a company with CNRS participation,undefined

来源：

Arthritis Research & Therapy | / 23卷

关键词：

Systemic lupus erythematosus; Autoimmune diseases; Treatment; Arsenic trioxide; Phase II clinical trial;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Zhou, Huixing
Wang, Yafei
Chen, Jiao
He, Aili
Jin, Jie
Lu, Quanyi
Zhao, Ying
Li, Junjun
Hou, Ming
Su, Liping
Lai, Xun
Wang, Wei
Liu, Lihong
Ma, Yanping
Gao, Da
Lai, Wenhong
Zhou, Xin
Jing, Hongmei
Zhang, Jinqiao
Yang, Wei
Ran, Xuehong
Lin, Congmeng
Hao, Jianping
Xiao, Taiwu
Huang, Zhenqian
Zhu, Zhigang
Wang, Qing
Fang, Baijun
Wang, Binghua
Song, Yanping
Cai, Zhen
Liu, Bo
Zhu, Yanan
Yang, Xinai
Kang, Xiaoyan
Li, Juan
Chen, Wenming
ANNALS OF HEMATOLOGY, 2024, 103 (03) : 855 - 868
[42] Efficacy and safety of generic pomalidomide plus low-dose dexamethasone in relapsed or refractory multiple myeloma: a multicenter, open-label, single-arm trial
Huixing Zhou
Yafei Wang
Jiao Chen
Aili He
Jie Jin
Quanyi Lu
Ying Zhao
Junjun Li
Ming Hou
Liping Su
Xun Lai
Wei Wang
Lihong Liu
Yanping Ma
Da Gao
Wenhong Lai
Xin Zhou
Hongmei Jing
Jinqiao Zhang
Wei Yang
Xuehong Ran
Congmeng Lin
Jianping Hao
Taiwu Xiao
Zhenqian Huang
Zhigang Zhu
Qing Wang
Baijun Fang
Binghua Wang
Yanping Song
Zhen Cai
Bo Liu
Yanan Zhu
Xinai Yang
Xiaoyan Kang
Juan Li
Wenming Chen
Annals of Hematology, 2024, 103 : 855 - 868
[43] Comparison of Low-Dose Rosuvastatin with Atorvastatin in Lipid-Lowering Efficacy and Safety in a High-Risk Pakistani Cohort: An Open-Label Randomized Trial
Arshad, Abdul Rehman
JOURNAL OF LIPIDS, 2014, 2014
[44] Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study
Altman, Roy D.
Strand, Vibeke
Hochberg, Marc C.
Gibofsky, Allan
Markenson, Joseph A.
Hopkins, William E.
Cryer, Byron
Kivitz, Alan
Nezzer, Jennifer
Imasogie, Olaolu
Young, Clarence L.
POSTGRADUATE MEDICINE, 2015, 127 (05) : 517 - 528
[45] Pharmacokinetic, Pharmacodynamic, and Safety Profile of Subcutaneous Belimumab in Pediatric Patients with Systemic Lupus Erythematosus: Analysis of Data from a Multicenter, Open-Label Trial
Brunner, Hermine
Oscar Viola, Diego
Dimelow, Richard
Calvo Penades, Inmaculada
Wilkinson, Christel
Rizo Rodriguez, Juan Cruz
Boteanu, Alina
Kamphuis, Sylvia
Minden, Kirsten
Horneff, Gerd
Anton, Jordi
Mori, Masaaki
Yamasaki, Yuichi
Olaiz, Jose Miyar
Marino, Rebecca
van Maurik, Andre
Okily, Mohamed
Yanni, Emad
Wilde, Paul
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2437 - 2439
[46] ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS - A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL
Gopaluni, Seerapani
Goymer, Donna
McClure, Mark
Cahill, Hugh
Broadhurst, Elizabeth
Smith, Rona
Jayne, David
RHEUMATOLOGY, 2019, 58
[47] Low-Dose Quetiapine for Adolescents With Autistic Spectrum Disorder and Aggressive Behavior: Open-Label Trial
Golubchik, Pavel
Sever, Jonathan
Weizman, Abraham
CLINICAL NEUROPHARMACOLOGY, 2011, 34 (06) : 216 - 219
[48] Adjunctive low-dose docosahexaenoic acid (DHA) for major depression: An open-label pilot trial
Smith, Deidre J.
Sarris, Jerome
Dowling, Nathan
O'Connor, Manjula
Ng, Chee H.
NUTRITIONAL NEUROSCIENCE, 2018, 21 (03) : 224 - 228
[49] A 6-MONTH OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND EFFICACY OF INTRAVENOUS BELIMUMAB IN PATIENTS WITH LUPUS NEPHRITIS
Furie, R.
Rovin, B. H.
Houssiau, F.
Contreras, G.
Curtis, P.
Madan, A.
Jones-Leone, A.
Okily, M.
Roth, D.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 591 - 592
[50] Modulatory Effect of the Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen on Circulating Immune Cells in Systemic Lupus Erythematosus
Gabriela Gabcova
Pavel Horak
Zuzana Mikulkova
Martina Skacelova
Sarka Zehnalova
Andrea Smrzova
Anna Petrackova
Frantisek Mrazek
Eva Kriegova
Archivum Immunologiae et Therapiae Experimentalis, 2019, 67 : 415 - 425

← 1 2 3 4 5 →